Skip to main content
Download PDF

Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer

Breast Cancer Research volume 26, Article number: 46 (2024) Cite this article

The Original Article was published on 26 February 2024

Correction to: Shatsky et al. Breast Cancer Research (2024) 26:32https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01782-0

The original article contained three typesetting errors. “Her2-negative” in the title should have been written as “HER2-negative”. Hence, the title should read: A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer, as shown in this Correction Article. 

In the Background section of the original article, on page 2, paragraph 2, there was a misspelling of “immuneodeficient”. The correct spelling is “immunodeficient.”

Also on page 2, in the section on Patient Selection, there was a misspelling of “HERer2”. The correct spelling is “HER2-” as displayed throughout the manuscript.

The original article [1] has been updated.

References

  1. Shatsky RA, Batra-Sharma H, Helsten T, et al. A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer. Breast Cancer Res. 2024;26:32. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01782-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive Mail Code 0987, La Jolla, San Diego, CA, 92093, USA

    Rebecca A. Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B. Schwab, Emily I. Pittman, Minya Pu, Emanuela M. Ghia, Laura Z. Rassenti, Alfredo Molinolo, Karen Messer, Catriona Jamieson, Thomas J. Kipps & Barbara A. Parker

  2. Department of Medicine, University of California San Diego, La Jolla, San Diego, CA, USA

    Rebecca A. Shatsky, Hemali Batra-Sharma, Teresa Helsten, Richard B. Schwab, George F. Widhopf II, Catriona Jamieson & Barbara A. Parker

  3. Herbert Wertheim School of Public Health, University of California San Diego, La Jolla, San Diego, CA, USA

    Karen Messer

  4. Department of Radiology, University of California San Diego, La Jolla, San Diego, CA, USA

    Elizabeth Weihe

  5. Center for Novel Therapeutics, University of California San Diego, La Jolla, San Diego, CA, USA

    Emanuela M. Ghia, Laura Z. Rassenti, George F. Widhopf II & Thomas J. Kipps

  6. University of California San Diego California Institute for Regenerative Medicine Alpha Clinic, La Jolla, San Diego, CA, USA

    Betty Cabrera & Catriona Jamieson

  7. Oncternal Therapeutics, Inc., San Diego, CA, USA

    James B. Breitmeyer

  8. Sanford Stem Cell Institute, University of California San Diego, La Jolla, San Diego, CA, USA

    Catriona Jamieson

Authors
  1. Rebecca A. Shatsky
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Hemali Batra-Sharma
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Teresa Helsten
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Richard B. Schwab
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Emily I. Pittman
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Minya Pu
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Elizabeth Weihe
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Emanuela M. Ghia
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Laura Z. Rassenti
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Alfredo Molinolo
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Betty Cabrera
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. James B. Breitmeyer
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. George F. Widhopf II
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. Karen Messer
    View author publications

    You can also search for this author inPubMed Google Scholar

  15. Catriona Jamieson
    View author publications

    You can also search for this author inPubMed Google Scholar

  16. Thomas J. Kipps
    View author publications

    You can also search for this author inPubMed Google Scholar

  17. Barbara A. Parker
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Barbara A. Parker.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01782-0.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shatsky, R., Batra-Sharma, H., Helsten, T. et al. Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer. Breast Cancer Res 26, 46 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01805-w

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13058-024-01805-w

Breast Cancer Research

ISSN: 1465-542X

Contact us